2. Feigin VL, Forouzanfar MH, Krishnamurthi R, et al. Global and regional burden of stroke during

1990–2010: findings from the Global Burden of Disease Study 2010. Lancet 2014;383:245–254.

3. Koton S, Schneider AL, Rosamond WD, et al. Stroke incidence and mortality trends in US

communities, 1987 to 2011. JAMA 2014;312:259–268.

4. Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics–2014 update: a report

from the American Heart Association. Circulation 2014;129:e28–e292.

5. White H, Boden-Albala B, Wang C, et al. Ischemic stroke subtype incidence among whites, blacks,

and Hispanics: the Northern Manhattan Study. Circulation 2005;111:1327–1331.

6. Schneider AT, Kissela B, Woo D, et al. Ischemic stroke subtypes: a population-based study of

incidence rates among blacks and whites. Stroke 2004;35:1552–1556.

7. Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics–2012 update: a report

from the American Heart Association. Circulation 2012;125:e2–e220.

8. Rothwell PM, Coull AJ, Giles MF, et al. Change in stroke incidence, mortality, case-fatality,

severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study). Lancet

2004;363:1925–1933.

9. Carandang R, Seshadri S, Beiser A, et al. Trends in incidence, lifetime risk, severity, and 30-day

mortality of stroke over the past 50 years. JAMA 2006;296:2939–2946.

10. O’Donnell MJ, Xavier D, Liu L, et al. Risk factors for ischaemic and intracerebral haemorrhagic

stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet 2010;376:112–123.

11. Mathiesen EB, Joakimsen O, B⊘naa KH. Prevalence of and risk factors associated with carotid

artery stenosis: the Troms⊘ Study. Cerebrovasc Dis 2001;12:44–51.

12. Kiechl S, Willeit J, Rungger G, et al. Quantitative assessment of carotid atherosclerosis in a healthy

population. Neuroepidemiology 1994;13:314–317.

13. Petty GW, Brown RD Jr., Whisnant JP, et al. Ischemic stroke subtypes : a population-based study of

functional outcome, survival, and recurrence. Stroke 2000;31:1062–1068.

14. Barnett HJ, Taylor DW, Eliasziw M, et al. Benefit of carotid endarterectomy in patients with

symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy

Trial Collaborators. N Engl J Med 1998;339:1415–1425.

15. Warlow CP. Symptomatic patients: the European Carotid Surgery Trial (ECST). J Mal Vasc

1993;18:198–201.

16. Blauw GJ, Lagaay AM, Smelt AH, et al. Stroke, statins, and cholesterol. A meta-analysis of

randomized, placebo-controlled, double-blind trials with HMG-CoA reductase inhibitors. Stroke

1997;28:946–950.

17. Brott TG, Halperin JL, Abbara S, et al. 2011

ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on the

management of patients with extracranial carotid and vertebral artery disease: executive summary.

A report of the American College of Cardiology Foundation/American Heart Association Task Force

on Practice Guidelines, and the American Stroke Association, American Association of Neuroscience

Nurses, American Association of Neurological Surgeons, American College of Radiology, American

Society of Neuroradiology, Congress of Neurological Surgeons, Society of Atherosclerosis Imaging

and Prevention, Society for Cardiovascular Angiography and Interventions, Society of

Interventional Radiology, Society of NeuroInterventional Surgery, Society for Vascular Medicine,

and Society for Vascular Surgery. Circulation 2011;124:489–532.

18. Roederer GO, Langlois YE, Jager KA, et al. The natural history of carotid arterial disease in

asymptomatic patients with cervical bruits. Stroke 1984;15:605–613.

19. Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the

Asymptomatic Carotid Atherosclerosis Study. JAMA 1995;273:1421–1428.

20. Nicolaides AN, Kakkos SK, Kyriacou E, et al. Asymptomatic internal carotid artery stenosis and

cerebrovascular risk stratification. J Vasc Surg 2010;52:1486–1496 e1–e5.

21. Mughal MM, Khan MK, DeMarco JK, et al. Symptomatic and asymptomatic carotid artery plaque.

Expert Rev Cardiovasc Ther 2011;9:1315–1330.

22. Bhatt DL, Fox KA, Hacke W, et al. Clopidogrel and aspirin versus aspirin alone for the prevention of

atherothrombotic events. N Engl J Med 2006;354:1706–1717.

23. Gurm HS, Yadav JS, Fayad P, et al. Long-term results of carotid stenting versus endarterectomy in

2566

high-risk patients. N Engl J Med 2008;358:1572–1579.

24. Mas JL, Chatellier G, Beyssen B, et al. Endarterectomy versus stenting in patients with symptomatic

severe carotid stenosis. N Engl J Med 2006;355:1660–1671.

25. Brott TG, Hobson RW 2nd, Howard G, et al. Stenting versus endarterectomy for treatment of

carotid-artery stenosis. N Engl J Med 2010;363:11–23.

26. Stingele R, Berger J, Alfke K, et al. Clinical and angiographic risk factors for stroke and death

within 30 days after carotid endarterectomy and stent-protected angioplasty: a subanalysis of the

SPACE study. Lancet Neurol 2008;7:216–222.

27. Carotid Stenting Trialists Collaboration, Bonati LH, Dobson J, et al. Short-term outcome after

stenting versus endarterectomy for symptomatic carotid stenosis: a preplanned meta-analysis of

individual patient data. Lancet 2010;376:1062–1073.

28. Facco E, Deriu GP, Dona B, et al. EEG monitoring of carotid endarterectomy with routine patchgraft angioplasty: an experience in a large series. Neurophysiol Clin 1992;22:437–446.

29. Phillips MR, Johnson WC, Scott RM, et al. Carotid endarterectomy in the presence of contralateral

carotid occlusion: the role of EEG and intraluminal shunting. Arch Surg 1979;114:1232–1239.

30. Thompson JE. Complications of carotid endarterectomy and their prevention. World J Surg

1979;3:155–165.

31. Javid H, Julian OC, Dye WS, et al. Seventeen-year experience with routine shunting in carotid

artery surgery. World J Surg 1979;3:167–177.

32. Kresowik TF, Bratzler D, Karp HR, et al. Multistate utilization, processes, and outcomes of carotid

endarterectomy. J Vasc Surg 2001;33:227–234; discussion 234–235.

33. Wallaert JB, Goodney PP, Vignati JJ, et al. Completion imaging after carotid endarterectomy in the

Vascular Study Group of New England. J Vasc Surg 2011;54:376–385, 85 e1–e3.

34. Kinney EV, Seabrook GR, Kinney LY, et al. The importance of intraoperative detection of residual

flow abnormalities after carotid artery endarterectomy. J Vasc Surg 1993;17:912–922; discussion

922–923.

35. Hertzer NR, Lees CD. Fatal myocardial infarction following carotid endarterectomy: three hundred

thirty-five patients followed 6–11 years after operation. Ann Surg 1981;194:212–218.

36. O’Donnell TF Jr, Callow AD, Willet C, et al. The impact of coronary artery disease on carotid

endarterectomy. Ann Surg 1983;198:705–712.

37. Cunningham EJ, Bond R, Mayberg MR, et al. Risk of persistent cranial nerve injury after carotid

endarterectomy. J Neurosurg 2004;101:445–448.

38. Group SC, Ringleb PA, Allenberg J, et al. 30 day results from the SPACE trial of stent-protected

angioplasty versus carotid endarterectomy in symptomatic patients: a randomised non-inferiority

trial. Lancet 2006;368:1239–1247.

39. Stanley JC, Fry WJ, Seeger JF, et al. Extracranial internal carotid and vertebral artery

fibrodysplasia. Arch Surg 1974;109:215–222.

40. Mettinger KL, Ericson K. Fibromuscular dysplasia and the brain. I. Observations on angiographic,

clinical and genetic characteristics. Stroke 1982;13:46–52.

41. Bogousslavsky J, Regli F. Ischemic stroke in adults younger than 30 years of age. Cause and

prognosis. Arch Neurol 1987;44:479–482.

42. Ehrnefeld WK, Stoney RJ, Wylie EJ. Relation of carotid stump pressure to safety of carotid artery

ligation. Surgery 1983;93:299–305.

43. Sen I, Stephen E, Malepathi K, et al. Neurological complications in carotid body tumors: a 6-year

single-center experience. J Vasc Surg 2013;57:64S–8S.

44. Caplan LR, Wityk RJ, Glass TA, et al. New England Medical Center Posterior Circulation registry.

Ann Neurol 2004;56:389–398.

45. McDowell FH, Potes J, Groch S. The natural history of internal carotid and vertebral-basilar artery

occlusion. Neurology 1961;11(4)Pt 2:153–157.

46. Labauge R, Boukobza M, Pages M, et al. [Occlusion of the vertebral artery (100 personal cases)].

Rev Neurol 1987;143:490–509.

47. Berguer R, Higgins R, Nelson R. Noninvasive diagnosis of reversal of vertebral-artery blood flow. N

Engl J Med 1980;302:1349–1351.

2567

48. Berguer R, Morasch MD, Kline RA. A review of 100 consecutive reconstructions of the distal

vertebral artery for embolic and hemodynamic disease. J Vasc Surg 1998;27:852–829.

49. Berguer R, Flynn LM, Kline RA, et al. Surgical reconstruction of the extracranial vertebral artery:

management and outcome. J Vasc Surg 2000;31:9–18.

50. Investigators SS. Stenting of Symptomatic Atherosclerotic Lesions in the Vertebral or Intracranial

Arteries (SSYLVIA): study results. Stroke 2004;35:1388–1392.

51. Coward LJ, Featherstone RL, Brown MM. Percutaneous transluminal angioplasty and stenting for

vertebral artery stenosis. Cochrane Database Syst Rev 2005:CD000516.

52. Layton KF, Kallmes DF, Cloft HJ, et al. Bovine aortic arch variant in humans: clarification of a

common misnomer. AJNR Am J Neuroradiol 2006;27:1541–1542.

53. Stone WM, Brewster DC, Moncure AC, et al. Aberrant right subclavian artery: varied presentations

and management options. J Vasc Surg 1990; 11:812–817.

54. Kieffer E, Bahnini A, Koskas F. Aberrant subclavian artery: surgical treatment in thirty-three adult

patients. J Vasc Surg 1994;19:100–109; discussion 110–111.

55. Bisognano JD, Young B, Brown JM, et al. Diverse presentation of aberrant origin of the right

subclavian artery: two case reports. Chest 1997;112:1693–1697.

56. Berguer R, Morasch MD, Kline RA, et al. Cervical reconstruction of the supra-aortic trunks: a 16-

year experience. J Vasc Surg 1999;29:239–246; discussion 246–248.

57. Kieffer E, Sabatier J, Koskas F, et al. Atherosclerotic innominate artery occlusive disease: early and

long-term results of surgical reconstruction. J Vasc Surg 1995;21:326–336; discussion 336–337.

58. Berguer R, Morasch MD, Kline RA. Transthoracic repair of innominate and common carotid artery

disease: immediate and long-term outcome for 100 consecutive surgical reconstructions. J Vasc Surg

1998;27:34–41; discussion 42.

59. Rhodes JM, Cherry KJ Jr., Clark RC, et al. Aortic-origin reconstruction of the great vessels: risk

factors of early and late complications. J Vasc Surg 2000;31:260–269.

60. Byrne J, Darling RC 3rd, Roddy SP, et al. Long term outcome for extra-anatomic arch

reconstruction. An analysis of 143 procedures. Eur J Vasc Endovasc Surg 2007;34:444–450.

61. Bates MC, Broce M, Lavigne PS, et al. Subclavian artery stenting: factors influencing long-term

outcome. Catheter Cardiovasc Interv 2004;61:5–11.

62. De Vries JP, Jager LC, Van den Berg JC, et al. Durability of percutaneous transluminal angioplasty

for obstructive lesions of proximal subclavian artery: long-term results. J Vasc Surg 2005;41:19–23.

63. Przewlocki T, Kablak-Ziembicka A, Pieniazek P, et al. Determinants of immediate and long-term

results of subclavian and innominate artery angioplasty. Catheter Cardiovasc Interv 2006;67:519–

526.

2568